CLINICAL_TRIALS
trial_result
· 2014-02-11
Clinical Trial Update: Initial Study of Malaria Vaccine Pfs25-EPA/Alhydrogel(Registered Trademark) [Phase 1]
Summary
Phase 1 clinical trial evaluating the malaria vaccine Pfs25-EPA/Alhydrogel has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Malaria | Phase 1 | Status: COMPLETED